| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Furosemide | Furosemide EP Impurity A | VL61003 | View CAS 4818-59-1 |
| Furosemide | Furosemide EP Impurity B | VL61005 | View CAS 2736-23-4 |
| Furosemide | Furosemide EP Impurity C | VL61004 | View CAS 3086-91-7 |
| Furosemide | Furosemide EP Impurity D | VL61001 | View CAS 5046-19-5 |
| Furosemide | Furosemide EP Impurity E | VL61002 | View CAS 50-84-0 |
| Furosemide | Furosemide EP Impurity F | VL61006 | View CAS 4793-38-8 |
| Catalogue No. | VL61005 |
| CAS No. | 2736-23-4 |
| Molecular Formula | C7H5Cl2NO4S |
| Molecular Weight | 270.09 |
| Parent drug | Furosemide |
| IUPAC Name | 3-Sulfamoyl-4, 6-dichlorobenzoic acid |
| Synonyms | 2,4-dichloro-5-sulfamoylbenzoic acid |
| References | “Sci-Hub, Mechanism of Furosemide Resistance in Analbuminemic Rats and Hypoalbuminemic Patients. Kidney International, 32(2), 198–203, 10.1038/Ki.1987.192.” Hkvisa.net, 2022, sci-hub.hkvisa.net/www.sciencedirect.com/science/article/pii/S008525381534062X. |
| Status | In-stock |
| ListName | Furosemide EP Impurity B |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
